| MGICX | VTISX | MGICX / VTISX | |
| Total Expense Ratio | 1.77 | 0.05 | 3,766% |
| Annual Report Gross Expense Ratio | 1.78 | 0.05 | 3,787% |
| Fund Existence | 29 years | 9 years | - |
| Gain YTD | 29.167 | 28.929 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 24.4B | 554B | 4% |
| Annual Yield % from dividends | 0.78 | 2.75 | 28% |
| Returns for 1 year | 12.62 | 25.12 | 50% |
| Returns for 3 years | 8.48 | 49.36 | 17% |
| Returns for 5 years | -15.53 | 39.69 | -39% |
| Returns for 10 years | 27.30 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CTWO | 18.95 | 0.35 | +1.88% |
| COtwo Advs Physical Eur Carb AllowanceTr | |||
| FLCA | 46.36 | 0.62 | +1.35% |
| Franklin FTSE Canada ETF | |||
| FTXH | 31.49 | 0.18 | +0.57% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| ECML | 32.19 | N/A | N/A |
| Euclidean Fundamental Value ETF | |||
| PDBC | 13.69 | -0.17 | -1.23% |
| Invesco Optm Yd Dvrs Cdty Stra No K1 ETF | |||